Literature DB >> 12053391

Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up.

M Carminati1, M Chessa, G Butera, R M Bini, S Giusti, P Festa, I Spadoni, S Redaelli, G Hausdorf.   

Abstract

BACKGROUND: The STARFlex (SF) device is a CardioSEAL (CS) double-umbrella device that has been modified by the addition of a self-centering mechanism comprised of nitinol springs connected between the two umbrellas and a flexible core wire with a pin-pivoting connection. This paper compares the results of atrial septal defect (ASD) closure with CardioSEAL and STARFlex devices. PATIENTS AND METHODS: Between December 1996 and March 2000, 117 patients underwent ASD closure with CardioSEAL (n = 79) and STARFlex (n = 38). The mean age (17 years), weight (49 kg), and ASD size (15 mm) were similar in the two groups. The procedures were performed under general anesthesia with both fluoroscopic and transesophageal echocardiographic monitoring. IMMEDIATE
RESULTS: The devices were successfully implanted in all patients. Ten patients had multiple ASDs. A single device was used in four patients (CardioSEAL in three, STARFlex in one), while a simultaneous placement of two CardioSEAL (one patient) or two STARFlex (five patients) were performed in six patients. The results are summarized as follows: [table: see text] Follow-Up
Results: On follow-up clinical exam, electrocardiograms, chest X-rays, and echocardiograms were obtained at 1, 6, and 12 months. [table: see text] During follow-up there were no deaths, endocarditis, rhythm disturbances, or other complications. Arm fractures were observed almost exclusively with large CardioSEAL devices (40 mm, less frequently with 33 mm), and only in one 33-mm STARFlex device. There were no clinical complications related to fractures.
CONCLUSIONS: The STARFlex device seems to offer better results than the CardioSEAL, with significantly lower rates of residual shunts and arm fractures.

Entities:  

Mesh:

Year:  2001        PMID: 12053391     DOI: 10.1111/j.1540-8183.2001.tb00339.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  7 in total

Review 1.  Closing down: transcatheter closure of intracardiac defects and vessel embolisations.

Authors:  Jean-François Piéchaud
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 2.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

3.  Morphogenetic differences of secundum atrial septal defects.

Authors:  N A Blom; J Ottenkamp; T H Jongeneel; M C DeRuiter; A C Gittenberger-de Groot
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

4.  Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and long-term results.

Authors:  Christian Spies; Ines Timmermanns; Rainer Schräder
Journal:  Clin Res Cardiol       Date:  2007-02-26       Impact factor: 5.460

5.  Right to left shunt through interatrial septal defects in patients with congenital heart disease: results of interventional closure.

Authors:  G Agnoletti; Y Boudjemline; P Ou; D Bonnet; D Sidi
Journal:  Heart       Date:  2005-11-03       Impact factor: 5.994

6.  Transcatheter closure of atrial septal defect in symptomatic children weighing ≤10 kg: Addressing unanswered issues from a decade of experience.

Authors:  Bharti Sharma; Robin Pinto; Bharat Dalvi
Journal:  Ann Pediatr Cardiol       Date:  2019-12-04

7.  Persistent Atrial Septum Defect Despite Placement of Two Amplatzer Septal Occluders.

Authors:  Kay B Leissner; Jahan Porhomayon; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2015-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.